Enfusion

Enfusion Equity Turnover

Delisted

The Equity Turnover of Enfusion (ENFN) as of Nov 7, 2026 is 2.75. In the previous year, Equity Turnover was 3.25 — a change of -15.34% (lower).

Equity Turnover

2.75

YoY

-15.34%

Last updated:

Equity Turnover of Enfusion is 2024 2.75 . Equity Turnover of Enfusion was 2023 3.25 . It decreases by -15.34% lower compared to the previous year.

The Enfusion Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2019
-0.50 USD
Jan 1, 2020
-0.34 USD
Jan 1, 2021
2.02 USD
Jan 1, 2022
2.31 USD
Jan 1, 2023
3.25 USD
Jan 1, 2024
2.75 USD
The Enfusion Equity Turnover history
YEAREquity TurnoverYoY
2.75-15.34%
3.25+40.62%
2.31+14.49%
2.02-693.00%
-0.34-31.97%
-0.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Equity Turnover of Enfusion is 2.75 in 2024.

Equity Turnover of Enfusion changed from 3.25 to 2.75, representing a -15.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Enfusion since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Enfusion with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Enfusion

All Key Metrics — Enfusion